Matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) has proven to be an effective identification tool in medical microbiology. Discrimination to subspecies or serovar level has been found to be challenging using commercially available identification software. By forming our own reference database and using alternative analysis methods, we could reliably identify all implemented Enterobacteriaceae and non-fermenting gram negative bacilli by MALDI-TOF MS and even succeeded to distinguish Shigella sonnei from Escherichia coli (E. coli) and Salmonella enterica spp. enterica serovar Enteritidis from Salmonella enterica spp. enterica serovar Typhimurium. Furthermore, the method showed the ability to separate Enterohemorrhagic E. coli (EHEC) and Enteropathogenic E. coli (EPEC) from non-enteropathogenic E. coli.
Since matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) has become a more and more effective tool for species identification in clinical microbiology [1] [2] [3] [4] , many studies tried to evaluate its performance compared to conventional phenotypic and genotypic identification systems [5] [6] [7] [8] [9] [10] [11] . Especially by using commercially available MALDI-TOF MS data analysis software, satisfying results in the discrimination of predominantly gram negative bacilli were achieved. Some authors already encountered difficulties in the discrimination of closely related species and began to develop alternative, not commercially available, analysis software.
In order to optimize reliable discrimination we evaluated the performance of MALDI-TOF MS in the identification of gram negative bacilli based on a database containing strains previously identified by the API systems (bioMérieux S.A., Marcy L'Etoile, France) and checked reproducibility in a blindfolded study with strains previously identified by the VITEK II system (bioMérieux S.A.). Both tools are widely spread standard identification systems for bacteria [12] . As already indicated above, the aim of our study was not only to discriminate between genetically distinct species, but also between closely related species like E. coli and Shigella Since we already achieved good results by using our own, alternative statistical analysis software in recent studies [13] [14] [15] , we attempted to optimize identification rates for gram negative bacilli by MALDI-TOF MS by establishing our own database of gram negative bacilli with a total of 219 strains from 17 species and 12 genera. Fifteen species of Enterobacteriaceae and 2 species of non-fermenting gram negative bacilli were included ( Table 1) . As proposed by Seng et al. [7] , we established spectra of about 10 strains as a reference for each species in the database (for illustration see Fig. 1 ). Those strains were clinical isolates from the routine diagnostics laboratory of our institute.
Previous identification of the implemented strains from clinical specimens was conducted in a standard manner be-ginning with microbiological culture which yielded pure growth of lactose non-fermenting and fermenting Gram negative rods (selective medium Endo-Agar (bioMérieux S.A.). The strains were further identified by Gram stain and key reactions, i.e. KOH, indole, oxidase as well as with commercially available API systems (API 20 E, ID 32 E, ID 32 GN and API 20 NE, bioMérieux S.A.). Organisms identified as Salmonella spp. (lactose negative) were subjected to subsequent serovar determination by serotyping agglutination according to the Kauffmann-White scheme using Salmonella antisera from Sifin (SIFIN Institut für Immunpräparate und Nährmedien GmbH, Berlin, Germany). Any inconsistent specimens were identified genotypically by 16S rDNA amplification which was performed with the primers 609V and 699R as described by Ackermann et al. [16] resulting in a PCR product of approx. 300 bp. Amplification sequences were compared using the NCBI BLAST database (http://www.ncbi.nlm.nih.-gov/blast/Blast.cgi).
All strains were isolated from clinical specimens, including blood cultures, wound swabs, urine, stool and specimens from the respiratory tract, i.e. sputum, tracheal aspirate, bronchoalveolar lavage (BAL) and tissue specimens. Proteus mirabilis 20 152
Proteus vulgaris 10 78
Salmonella Enteritidis 10 80
Salmonella Typhimurium 10 80
Serratia marcescens 10 80
Shigella sonnei 9 71
Yersinia enterocolitica 9 70
Citrobacter freundii 10 77
Morganella morganii 8 57
Acinetobacter baumanii 10 80
Pseudomonas aeruginosa 37 219
Total 219 1626 *Multiple spectra from a total of four specimens per each single strain were acquired at two distinct dates to check reproducibility and taking strain and recording specific variations into account. To check the accuracy of our database and to evaluate MALDI-TOF MS discrimination potential compared to another phenotypic detection system (VITEK II), 99 strains isolated from clinical specimens (blood cultures, wound swabs, urine, stool and specimens from the respiratory tract, i.e. sputum, tracheal aspirate, broncheoalveolar lavage and tissue specimens) and routinely identified by VITEK II in our lab were subjected to MALDI-TOF MS analysis in a blindfolded manner.
In order to analyze bacterial specimens by MALDI-TOF MS, multiple colonies from a pure culture were transferred to plastic tubes and cell lysis was conducted with trifluoroacetic acid (Merck, Darmstadt, Germany). The centrifuged cell lysates were brought to MALDI-TOF MS stainless steel target plates after vacuum centrifugation and α-cyano-4-hydroxycinnamic acid (Bruker Daltonics, Bremen, Germany) was used as a matrix [15] .
MALDI-TOF MS spectra were acquired with a Bruker Autoflex II mass spectrometer (Bruker Daltonics, Germany) with a nitrogen laser (λ=337nm) operated in the positive linear mode (delay 350ns, voltage 20 kV; mass over charge ratio (m/z) ranging from 2,000 to 12,000) under control of FlexControl software (version 2.4; Bruker Daltonics). Each spectrum was obtained by averaging 500 laser shots acquired in automatic mode at the minimum laser power being necessary for ionization of the samples. The calibration strain for each MALDI-TOF MS optical measurement was E. coli GSM 2163 from New England BioLabs. Data files were transferred to FlexAnalysis software (version 2.4; Bruker Daltonics) for automated peak extraction. With this software, 5 0 peaks were automatically labeled in each spectrum according to their appearance above the background (threshold ratio 1.5). Correct labeling was controlled manually. Peak lists containing masses and intensities were exported as Excel-files [14, 15] .
The data analysis was not performed by the Biotyper system provided by Bruker Daltonics, but by MatLab based algorithms (Version 7.10.0.499; The Math-Works Inc., Natick, MA) which were edited at the Institute of Biochemistry [14, 15] . Thus, peaks from all spectra belonging to one species were aligned to species-specific peak-clusters by forming mass-dependent windows over the peaks, taking the strain-and recording-specific variations of peak masses into account. Statistical similarity analysis was carried out by hierarchical clustering and dendrograms ware calculated on the basis of distance matrices by using a complete linkage function. For closely related species, we used classification algorithms, based on support-vector-machines (SVM) featuring an efficient two class classification. This was achieved by training the algorithm with a set of spectra of bacteria of known identity, according to our reference database. An error estimate of the class prediction was carried out by calculation of a 10-fold cross-validation error for the training group. For this purpose, the training set was first divided into 10 subsets of equal size. Sequentially, one subset was tested by using the classifier trained on the remaining nine subsets. Thus, each probe of the training set was predicted once. The cross-validation accuracy is the percentage of data which were correctly classified (correct rate) [14, 15] . While establishing the reference database we soon achieved excellent results in discriminating the species from one another by using statistical similarity analysis software. SVM algorithms were necessary for the separation of E. coli and Shigella sonnei and the two salmonella serovars. In some cases Enterobacter cloacae (E. cloacae) clustered together with E. coli and Shigella sonnei -in those cases SVM application could also resolve the discrepancies. In order to proof our results while establishing the database we subjected the 99 strains identified by VITEK II to MALDI-TOF MS identification.
The blindfolded study showed that MALDI-TOF MS could correctly identify 95% of the strains according to the previous VITEK II identification. Four strains were misidentified: one K. pneumoniae as E. coli (S36), one Enterobacter aerogenes (E. aerogenes) as Serratia marcescens (S. marcescens) (S37), one E. cloacae as E. coli (S89), and one Shigella sonnei as E. coli (S67). The four strains were subsequently subjected to API identification and 16s rDNA sequencing to resolve the discrepancies.
By this re-testing procedure isolate S37 was identified as S. marcescens and isolate S67 as Shigella sonnei. The two remaining misidentified specimen could not be identified unequivocally and were excluded from our study. In conclusion, a correct identification rate of 99% was achieved. Even Shigella sonnei was correctly distinguished from E. coli in 4 of 5 cases and the closely related S. enterica spp. enterica serovar Enteritidis and S. enterica spp. enterica serovar Typhimurium were properly identified ( Table 2) . Table 2 illustrates our results in the identification by MALDI-TOF MS compared to the VITEK II machine. As inconsistencies have arisen, those specimens were identified by another biochemical method (API) or even by serological and genotypic methods as mentioned above. The third column illustrates the results after the second identification (retesting). The correct identification rate is calculated on the match after the re-testing.
In addition, we evaluated the performance of our analysis software in the discrimination of non-enteropathogenic E. coli from its pathotypes Enteropathogenic E. coli (EPEC) and Enterohemorrhagic E. coli (EHEC), respectively. Spectra of 12 EPEC and 7 EHEC strains, previously identified by genotypic systems as mentioned above [16] and according to Hauswaldt et al. [17] (also including Endo-Agar selective growth and beta-lactamase screening by Etest (AB bioMérieux, Solna, Sweden)), were acquired. Further analysis was conducted as described for the aforementioned study. Definite discrimination was achieved by using SVM algorithms, where one class was defined by the known spectra of non-enteropathogenic E. colis from our database and the other by those of one of the pathotypes, respectively. The classification resulted in a correct rate of 96% for EHEC and a correct rate of 97% for EPEC indicating a reliable discrimination of the two pathotypes from non-enteropathogenic E. coli. 
